INTERSECT ENT, INC.
MENLO PARK, CA

Intersect ENT, Inc., founded on September 6, 2012, is a company dedicated to transforming ear, nose, and throat (ENT) care through the provision of innovative and clinically meaningful therapies for physicians and patients. Headquartered at 710 Medtronic Parkway in Minneapolis, MN, with mailings directed from Menlo Park, Leon County, Intersect ENT has established itself within the biotechnology sector as a pioneer in its field. The company is officially registered in Delaware (FEI Number: 200280837) and incorporated under Florida law with the file number F12000003661. Intersect ENT maintains strict policies regarding unsolicited ideas or suggestions, requiring that any feedback concerning products or technologies be provided via a formal process established by the company. This ensures clarity and legal protection for both the company and contributors. The organization is committed to fostering transparency in its business operations and has no obligation to review submissions without an agreed written contract. The leadership team includes President Amy Van Sach, Vice Presidents Anna Vincent and Danyel J Racenet, all playing crucial roles in guiding the strategic direction of Intersect ENT. Communication with the company can be facilitated through several contact numbers: (650) 641-2100, (866) 531-6004, (650) 641-2105, or (650) 454-0504. For further information about their products and services, visit the official website at intersectent.com. Intersect ENT’s most recent annual report was filed on April 17, 2024, reflecting its ongoing commitment to compliance and governance.